Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves’ disease
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.